Hepatitis C virus seroconversion among young injection drug users: relationships and risks. - Wikidata - awgldk - TriplyDB

Hepatitis C virus seroconversion among young injection drug users: relationships and risks.

Hepatitis C virus seroconversion among young injection drug users: relationships and risks.

http://www.wikidata.org/entity/Q43041146

about

A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and Treatment Self-reported hepatitis C virus antibody status and risk behavior in young injectors High levels of subgenomic HCV plasma RNA in immunosilent infections Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates Underlying Pathophysiology of HCV Infection in HIV-Positive Drug Users Improving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection Transition to injecting drug use in Iran: A systematic review of qualitative and quantitative evidence Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug users Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in China Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data.Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection.Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs.A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco.Strategies to avoid opiate withdrawal: implications for HCV and HIV risks Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort.Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis.Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users.Acute hepatitis C virus infection in incarcerated injection drug users.Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth Rethinking risk: gender and injection drug-related HIV risk among female sex workers and their non-commercial partners along the Mexico-U.S. border.Rare birds in North America: acute hepatitis C cohorts Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review.Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users.Are young injection drug users ready and willing to participate in preventive HCV vaccine trials?Prescription opioid misuse and its relation to injection drug use and hepatitis C virus infection: protocol for a systematic review and meta-analysis.Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy Inactivation and survival of hepatitis C virus on inanimate surfaces.Prescription drug misuse and risk behaviors among young injection drug users.

P2860

Q24617613-42C261E5-4111-494A-BCF4-7E1A32CD8EA7 Q24629455-A1966EE2-2A34-4012-842A-5FF36852E396 Q26991563-457349CA-5870-40D4-BFB1-29188D25314D Q27478003-3110FD4C-00F0-496C-99C2-8C1E0328C167 Q27481224-69E88AD2-FB3C-47C0-8ED6-43324C5D130E Q27485369-F8D0B47C-A8A3-4FAB-898F-87382578532C Q27489073-B93A4035-D25C-4555-A5A3-7C297392929B Q27489594-9078088A-80C7-4255-AE1A-9FE4781E5925 Q27490176-68E89F48-3D06-4770-954A-4BCF573AE1A3 Q28081444-51513112-4E1D-493E-9FF8-7CC852C237B1 Q28476518-7813D260-4777-4D53-BF8C-ED1844B5E388 Q28543558-AFFAD171-DA8C-4F6E-A920-E672AB6BC762 Q28550281-68E98725-E5EA-4BE6-8103-4F88F6584471 Q30209037-0E0CA52D-2B61-4334-8CCE-AB110C665E80 Q30226978-FA0AA06B-5821-46DA-9485-305C704D0CBC Q30369227-48438D83-B2AE-4498-9398-D50BCA3A585B Q30429470-F93F85AC-D0F0-4CC4-AB27-63B912D6E0C1 Q30713067-F12B2041-39E9-4BF1-839C-786A6BBEF489 Q30842338-DB8808B4-3E84-49EF-B21E-3C89F3C0FC43 Q31168171-20C4F022-31AD-498B-8603-4BF417F73A7A Q33483115-5C98F137-655E-4427-A8C2-769429469C16 Q33489194-4A7B75E3-4F1E-432A-806F-E3EA8E462007 Q33507211-6DD70513-D019-4284-A61A-07CA320AF8FD Q33650138-2026C7E6-7A6D-455A-AB79-D9C2D60CDB9F Q33691250-DC3225D2-72AE-48EF-9BCB-52BB43ED7D18 Q33707925-F74122BA-3201-4E25-9519-5F75228DDDB4 Q33752193-AC2F4F87-C6BB-486A-8D4D-7F37FBE9F69B Q33777428-EE108851-1B3E-48FC-8409-B753CA7544F6 Q33824723-C0D8F1E7-6481-45D0-88EB-61590E34B870 Q33995930-15566380-B6BD-4FE0-BDA0-46A1F2A410EF Q33996279-6524854D-0A55-4C5F-9E2D-E0DC26ADD537 Q34047059-C2FB71D3-576F-4F24-B873-3764975203DC Q34084126-0211A056-FEE5-4316-A031-D5045B21D48F Q34088235-49718253-5F22-4CC4-90F8-8A446EC2B421 Q34088245-F3AFC885-4E21-4197-8FC7-1787FB00327D Q34115061-7CA0C4CF-335E-4616-A07E-0B9421EB1370 Q34153684-251B5BC6-8402-4BC7-BB24-73C759A01B8F Q34167229-F89A1079-B35D-4B3F-B3F4-90C1FF8DB178 Q34225779-EA146187-7351-44F8-B042-1FA277E29A3F Q34287144-1F7D8CA7-C096-468B-BFA4-32ABBBD0096F

P2860

Hepatitis C virus seroconversion among young injection drug users: relationships and risks.

http://www.wikidata.org/entity/Q43041146

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Hepatitis C virus seroconversi ...... sers: relationships and risks.

@en

Hepatitis C virus seroconversi ...... sers: relationships and risks.

@nl

type

label

Hepatitis C virus seroconversi ...... sers: relationships and risks.

@en

Hepatitis C virus seroconversi ...... sers: relationships and risks.

@nl

prefLabel

Hepatitis C virus seroconversi ...... sers: relationships and risks.

@en

Hepatitis C virus seroconversi ...... sers: relationships and risks.

@nl

P1433

Q43041146-5E880A00-0C03-49E4-9544-621C2CDA90B0

P1476

Q43041146-55E314CD-6525-4936-AE77-6357A86C6305

P2093

Q43041146-23E2EBD0-F222-49E9-A005-3AD2112FCE74

Q43041146-3A7584FE-9B13-42A5-870C-758C40C7192F

Q43041146-46A4AE69-CF70-4570-B7E4-D844F21D95BD

Q43041146-498C1D6D-5BFD-4D34-BD79-19304C14E35B

Q43041146-4AF90A0E-174B-4EAF-AA7D-361DEE9092FD

Q43041146-9AB77EE5-6210-4185-BA1A-9C5E72772C4D

Q43041146-AEC5CF23-4AAE-4759-8F3A-63E240856413

Q43041146-C0D8AB9F-F87C-4FC7-BD93-1B1E70AAC058

Q43041146-D26F2D47-803D-4042-B11F-FB362119322E

P304

Q43041146-85734A1A-0A18-41ED-B412-FB1054AB152F

P31

Q43041146-E7EA5087-9A51-453B-93B5-48155E026C4B

P356

Q43041146-AA21A10F-AF7B-44DA-8A1A-73033C8742E1

P407

Q43041146-B9F1081B-C1EA-463D-A70F-6CAF11BB65EE

P433

Q43041146-134773F1-00BB-471C-885C-C09149768F95

P478

Q43041146-0A9D66C2-4AA0-4C52-8989-D4833022F89B

P50

Q43041146-A3198D45-E573-4FDB-9DB1-690CBEC1C0DA

P577

Q43041146-4D3D1515-5A74-4F33-A6ED-3E1B4D952705

P5875

Q43041146-578F9743-BF12-4762-9F37-C255A017242E

P698

Q43041146-C3CD919A-D67A-4F1B-9BBD-DBFA5BDC4205

P921

Q43041146-D606B1F6-3224-4D1E-831B-6F8B2A53F088

P356

P1433

The Journal of Infectious Diseases

P1476

Hepatitis C virus seroconversi ...... sers: relationships and risks.

@en

P2093

Andrew R Moss

http://www.w3.org/2001/XMLSchema#string

Bruce Phelps

http://www.w3.org/2001/XMLSchema#string

Ellen Stein

http://www.w3.org/2001/XMLSchema#string

Jennifer L Evans

http://www.w3.org/2001/XMLSchema#string

Judith A Hahn

http://www.w3.org/2001/XMLSchema#string

Kimberly Page-Shafer

http://www.w3.org/2001/XMLSchema#string

Leslie H Tobler

http://www.w3.org/2001/XMLSchema#string

Paula J Lum

http://www.w3.org/2001/XMLSchema#string

Philippe Bourgois

http://www.w3.org/2001/XMLSchema#string

P304

1558-1564

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/345554

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P50

Michael P. Busch

P577

2002-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11020961

http://www.w3.org/2001/XMLSchema#string

P698

12447730

http://www.w3.org/2001/XMLSchema#string

P921